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Abstract
The ATP6ap2 (Pro)renin receptor protein associates with  H+-ATPases which regulate organellar, cellular, and systemic 
acid–base homeostasis. In the kidney, ATP6ap2 colocalizes with  H+-ATPases in various cell types including the cells of the 
proximal tubule. There,  H+-ATPases are involved in receptor-mediated endocytosis of low molecular weight proteins via 
the megalin/cubilin receptors. To study ATP6ap2 function in the proximal tubule, we used an inducible shRNA Atp6ap2 
knockdown rat model (Kd) and an inducible kidney-specific Atp6ap2 knockout mouse model. Both animal lines showed 
higher proteinuria with elevated albumin, vitamin D binding protein, and procathepsin B in urine. Endocytosis of an injected 
fluid-phase marker (FITC- dextran, 10 kDa) was normal whereas processing of recombinant transferrin, a marker for receptor-
mediated endocytosis, to lysosomes was delayed. While megalin and cubilin expression was unchanged, abundance of several 
subunits of the  H+-ATPase involved in receptor-mediated endocytosis was reduced. Lysosomal integrity and  H+-ATPase 
function are associated with mTOR signaling. In ATP6ap2, KO mice mTOR and phospho-mTOR appeared normal but 
increased abundance of the LC3-B subunit of the autophagosome was observed suggesting a more generalized impairment 
of lysosomal function in the absence of ATP6ap2. Hence, our data suggests a role for ATP6ap2 for proximal tubule function 
in the kidney with a defect in receptor-mediated endocytosis in mice and rats.
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Introduction
The (pro)renin receptor ((P)RR) was identified as the recep-
tor for (pro)renin and renin [45, 67]. However, (P)RR expres-
sion is found also in organisms lacking a renin-angiotensin 
system suggesting additional functions [33, 46, 66, 67]. The 
(P)RR is an essential adaptor protein in the canonical Wnt 
signaling pathway [15] and participates also in non-canon-
ical Wnt signaling [9, 10, 23–26]. In humans, mutations in 
(P)RR cause epilepsy and intellectual impairment [58].
Part of the (P)RR has been recognized to be identi-
cal to the M8-9 protein, a potential accessory subunit of 
 H+-ATPases and (P)RR is thus also known as ATP6ap2 [36]. 
Additional studies confirmed protein–protein interactions 
between the (P)RR/ATP6ap2 and  H+-ATPases [41].
H+-ATPases are multi-subunit complexes that medi-
ate the transport of protons driven by hydrolysis of 
ATP.  H+-ATPases are composed of a membrane bound 
 V0 domain and a cytoplasmic  V1 domain. Its location 
is mainly in intracellular organelles like endosomes, 
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lysosomes, golgi apparatus, and secretory vesicles but it 
can also be found in the plasma membrane in organs like 
the kidney, epididymis, and bone [8, 71].  H+-ATPases are 
fundamental for acidification of late endosomes and lys-
osomes allowing membrane trafficking, protein degrada-
tion, and protein maturation [19, 37, 71]. ATP6ap2 shares 
 H+-ATPase location in the plasma membrane of renal and 
other cells [1, 17, 30, 59] but also in intracellular orga-
nelles [63]. The importance of  H+-ATPases in endocyto-
sis has been further confirmed in studies in mice lacking 
the  V0 domain  H+-ATPase a4 subunit in the kidney [22, 
48]. These animals presented a generalized impairment of 
proximal tubule functions with glycosuria, phosphaturia, 
and lysosomal defects. Similarly, humans and mice with 
mutations or loss of the ClC-5 chloride/proton exchanger, 
critical for lysosomal acidification and thought to work 
in tandem with endosomal and lysosomal  H+-ATPases, 
show impaired endocytosis and lysosomal function [14, 
53, 73]. Also in other organs,  H+-ATPase-mediated acidi-
fication of lysosomes and autophagosomes is critical for 
their function [20].
ATP6ap2 has been also linked to endocytosis in 
mouse and drosophila models. Conditional knockout 
mice for ATP6ap2 in podocytes and cardiomyocytes 
exhibit accumulation of autophagic vesicles suggesting 
lysosomal defects [49, 59]. In addition, embryonic fibro-
blast and podocyte cells in which ATP6ap2 was deleted 
showed a downregulation of several  V0  H+-ATPase sub-
units [30]. In drosophila, deletion of ATP6ap2 impaired 
Wnt signaling by reducing endosomal recycling of friz-
zled-related receptors, and reduced fluid-phase endo-
cytosis, both functions linked to reduced  H+-ATPase 
activity [25].
The kidney proximal tubule is among the most active 
endocytic tissues reabsorbing a large variety of proteins, 
small peptides, and peptidomimetic drugs via receptor-
mediated and fluid-phase endocytosis [47]. Receptor-medi-
ated endocytosis requires the presence and function of the 
endocytic receptors megalin and cubilin expressed in the 
brush border membrane and endocytic apparatus. Moreover, 
efficient acidification of the endocytic pathway is critical for 
recycling and processing of proteins, activation of lysoso-
mal enzymes and transporters, and lysosomal signaling via 
the mammalian target of rapamycin (mTOR) pathway [40, 
65, 68]. Several of these processes have been shown to be 
 H+-ATPase dependent [34, 37].
To date, the role of ATP6ap2 in the proximal tubule has 
not been elucidated. Here, we investigated ATP6ap2 func-
tion in proximal tubule using two different animal models. 
A rat model with an inducible shRNA for Atp6ap2 and an 
inducible kidney-epithelial cell-specific knockout mouse 
for ATP6ap2. We report that ATP6ap2 plays a role in 
cargo reabsorption and processing via receptor-mediated 




Generation and breeding of transgenic Atp6ap2 shRNA rats
Transgenic rats were generated as described previously [32]. 
Briefly, complementary sense and antisense oligonucleotides 
(rAtp6ap2sh3: 5′- TCC CCC TAC AAC CTT GCG TAT 
AAT TCA AGA GAT TAT ACG CAA GGT TGT AGG TTT 
TTT A -3′ and rAtp6ap2sh4: 5′- CGC GTA AAA AAC CTA 
CAA CCT TGC GTA TAA TCT CTT GAA TTA TAC GCA 
AGG TTG TAG G -3′) specifically targeting a sequence in 
the exon 9 of the rat (P)RR/Atp6ap2 mRNA were annealed 
and cloned into the bimodal pINV7 vector (Taconic) using 
the BbsI and MluI restriction sites.
To generate transgenic rats, a 4 kb DNA fragment con-
taining pTet-shAtp6ap2 (Fig. 1A) was cut out with the PacI 
and KpnI restriction enzymes, purified from the gel using 
a Wizard® SV Gel and PCR Clean-Up System (Promega), 
dissolved at 3  ng/μl with microinjection buffer (8  mM 
Tris–HCl, pH 7.4, and 0.15  mM EDTA) and microin-
jected into fertilized oocytes of Sprague–Dawley (SD) rats 
according to established techniques [54]. Integration of the 
transgene was detected by PCR in genomic DNA isolated 
from tail biopsies with the primers TetOfw: 5′ -TGC ATG 
TCG CTA TGT GTT CT -3′ and CAGGSrv: 5′- TGG CGT 
TAC TAT GGG AAC AT -3′. Using one positive newborn, 
the transgenic line ShAtp6ap2 was then established on the 
SD background. Negative littermates were used as wild type 
(Wt) controls.
Rats were maintained in individually ventilated cages 
under standardized, pathogen-free conditions (at a tempera-
ture of 21 ± 2 °C, humidity of 65 ± 5%, and with an artifi-
cial 12-h light/dark cycle) with free access to standard chow 
(0.25% sodium; SSNIFF) and drinking water ad libitum. All 
animal care and experiments were performed in accordance 
with the institutional guidelines of German Federal Law and 
local authorities of Berlin (LaGeSo).
Doxycycline treatment of rats in vivo
To induce expression of shRNA against ATP6ap2, animals 
were treated with 0.5 g/l doxycycline (Sigma) in the drinking 
water for 8 days. The doxycycline water was freshly pre-
pared each day and kept dark due to the light sensitivity. To 
confirm the functionality of the system, ATP6ap2 protein 
and RNA levels were analyzed in organs by western blot and 
real-time PCR, respectively.
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Fig. 1  Generation of the Atp6ap2 shRNA rat model and efficiency of 
Atp6ap2/(P)RR) knock-down. A Structure of the transgene construct, 
pTet-sh, made of two expression cassettes. A first one carries a tet-
racycline operator (tetO) sequence and expresses an shRNA against 
Atp6ap2 under the control of the human H1 promoter. A second cas-
sette consists of a tetracycline repressor (tetR) cDNA followed by a 
polyadenylation site (pA), and is driven by the CAGGS promoter. 
Primers TetOfw and CAGGSrv (arrows) were used for genotyping 
of rats. B Genotyping by PCR performed on newborn rat tails with 
a 195-bp PCR product characteristic of the transgenic animals (Sh). 
C Comparative expression of tetracycline repressor (TetR) protein 
between transgenic (Sh) and control (Wt) rats, as studied in various 
tissues by western blot. GAPDH was used as loading control. D RT-
qPCR analysis of total mRNA of kidneys from rat Wt and Sh demon-
strates successful knock-down of (P)RR/Atp6ap2 mRNA (n = 6/geno-
type). E Immunohistochemistry for the  H+ATPase a4 subunit (green), 
ATP6ap2 (red), and DAPI (blue) in kidney sections from Wt and Sh 
rats. Yellow overlay is seen in the Wt sections due to colocalization 
of a4 and ATP6ap2 while in sections from Sh rats only green stain-
ing for a4 is visible. Scale bar size: 50 µm. F Renal morphology of 
Sh and control animals. Semi-thin Sect. (200 nm thick) were stained 
with Toluidine Blue, scale bar size 100 µm
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Western blotting to confirm shAtp6ap2 rats
Rats were anesthetized with isoflurane followed by exsan-
guination. Tissues were collected, snap frozen in liquid 
nitrogen, coarsely ground using a mortar and pestle, and 
further homogenized in RIPA buffer (Cell Signaling) for 
protein extraction, using a FastPrep™-24 (MP Biomedicals) 
according to the manufacturer’s instructions. Total proteins 
were added to 4 × Roti®-load buffer (Carl Roth) and sepa-
rated by 12% SDS/PAGE. Proteins were then blotted on a 
PVDF membrane (Amersham Biosciences), which was sub-
sequently blocked with Odyssey® Blocking Buffer and incu-
bated with the following primary antibodies: mouse anti-
TetR (1:8000, MoBiTec) and rabbit anti-GAPDH (1:1000, 
Cell Signaling). Protein revelation was performed with an 
Odyssey® Infrared imaging system (LI-COR Biosciences) 
using IRdye® 800-coupled secondary antibodies (1:10,000, 
LI-COR Biosciences).
Kidney‑epithelial cell‑specific ATP6ap2 KO mice generation
The generation and genotype of  ATP6ap2flox/y has been 
already described [59]. Heterozygous ATP6ap2 flox/x females 
were crossed with males both positive for Pax8-rtTA and 
Cre [44, 69]. Expression of Cre-recombinase was induced 
in male  ATP6ap2flox/y,Pax8Cre+ and  ATP6ap2+/+,Pax8Cre+ trans-
genic mice by 1 mg/mL of doxycycline (Sigma) in drink-
ing water containing 2% of Sucrose (Sigma) for 5 days fol-
lowed by 5 days induction with 0.25 mg/mL doxycycline 
in 2% sucrose drinking water and 4 days without doxycy-
cline [44]. A second group of  ATP6ap2flox/y,Pax8Cre+ and 
 ATP6ap2+/+,Pax8Cre+ transgenic mice received 2 mg/mL 
doxycycline for 5 days followed by 5 days of 1 mg/mL doxy-
cycline in water containing 2% sucrose [69]. These groups 
are accordingly referred to as 1 mg and 2 mg doxycycline. 
Animals used for experiments were 2- to 3-month-old male 
mice bred in a C57BL/6 background. All animal studies 
were performed according to Swiss welfare laws and with 
approval of the local veterinary authorities.
Plasma and urine analysis
Blood was collected from the tail vein of anesthetized 
rats and vena cava from anesthetized mice. Heparinized 
blood was centrifuged at 7000 rpm for 7 min, plasma col-
lected, and rapidly frozen. Measurements of blood pH 
and blood electrolyte concentrations  (Na+,  K+,  Cl−,  Ca2+) 
were analyzed using an ABL80 FLEX CO-OX (Radiom-
eter, Copenhagen) and performed on heparinized tail vein 
blood. Urine was collected under mineral oil for 24 h in 
metabolic cages (Tecniplast®, Italy) and aliquots were 
rapidly frozen and stored at − 80 °C until measurement. 
Urine and plasma laboratory analyses were performed 
in the Zurich Integrative Rodent Physiology (ZIRP) core 
facility.
RNA extraction and RT‑qPCR
Harvested organs were snap frozen in liquid nitrogen. Total 
RNA was extracted using the Qiagen RNeasy Mini Kit (Qia-
gen, Hombrechtikon, Switzerland). Snap-frozen tissue slices 
were homogenized in a pestle homogenizer (Potter–Elve-
hjem type) together with 1 mL precooled RLT-Buffer sup-
plemented with β-mercaptoethanol at a final concentration 
of 1%. Subsequently, 350 µl of the homogenate was used 
for RNA preparation carried out according to the manufac-
turer’s instructions. DNase digestion was performed using 
the RNase-free DNase Set (Qiagen; Hilden, Germany). 
Total RNA extractions were analyzed for quality, purity, 
and concentration using the NanoDrop ND-1000 spectro-
photometer (Wilmington, DE, USA). RNA samples were 
diluted to a final concentration of 100 ng/µl and cDNA was 
prepared using the TaqMan Reverse Transcriptase Reagent 
Kit (Applied Biosystems, Roche; Forster City, CA, USA). In 
brief, in a reaction volume of 40 µl, 100 ng of RNA was used 
as template and mixed with the following final concentra-
tions of RT buffer (1x),  MgCl2 (5.5 mM), random hexam-
ers (2.5 µM), dNTP mix (500 µM each), RNase inhibitor 
(0.4 U/µl), multiscribe reverse transcriptase (1.25 U/µl), 
and RNAse-free water. Reverse transcription was performed 
with thermocycling conditions set at 25 °C for 10 min, 48 °C 
for 30 min, and 95 °C for 5 min on a thermocyler (Biometra, 
Goettingen, Germany).
Semi-quantitative real-time PCR (RT-qPCR) was per-
formed on the ABI PRISM 7700 Sequence Detection System 
(Applied Biosystems). Primers for Atp6ap2 were designed 
using Primer Express software from Applied Biosystems 
and purchased from Microsynth, Switzerland. Probes were 
labelled with the reporter dye FAM at the 5′-end and the 
quencher dye TAMRA at the 3′-end (Microsynth, Balgach, 
Switzerland).
For Mus musculus RT-qPCR, the following pair of prim-
ers for Atp6ap2 was used: forward 5′-GTG CTG GTC GTT 
CTC CTG TTC- 3′; reverse 5′-GGG ATT CGA TCT CCT GGT 
ATAG- 3′ together with a probe 5′GTG GCG GGT GCT TTA 
GGG AAT GAA T- 3′ which target only Atp6ap2 exon 2. For 
Rattus norvegicus Atp6ap2 RT-qPCR, we used: forward 
5′-TCG GAT CCT TGT TGA TGC TCTC -3′; reverse 5′- CTC 
ACC AGG GAT GTG TCG AA- 3′ primers and 5′- TGG GAA 
TGC AGT GGT AGA GTT GGT GA -3′ as probe. Real-time 
PCR reactions were performed using TaqMan Universal 
PCR Master Mix (Applied Biosystems) as described in the 
manufacturer’s user manual.
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Protein extraction and immunoblotting
Crude membrane and cytosolic proteins were extracted 
from half a kidney. Briefly, organs were homogenized in 
200 μl of ice-cold resuspension buffer (200 mM Mannitol, 
80 mM HEPES, 41 mM KOH, pH 7.5 supplemented with 
1 tablet/10 mL Complete Mini Protease Inhibitor Cocktail, 
Roche) using a Polytron homogenizer (0.5 mm diameter 
at 20,000 rpm for 1 min at 4 °C). The homogenate cen-
trifuged at 2000 rpm for 20 min at 4 °C. The resulting 
supernatant was further centrifuged at 41,000 rpm for 1 h 
at 4 °C. Brush border membrane protein preparation was 
performed according to the  Mg2+ precipitation procedure 
[6].
Tissue and urine samples were normalized for pro-
tein or creatinine levels, respectively, diluted in Lae-
mmli buffer, heated at 95° for 5 min, and separated by 
SDS–polyacrylamide gels electrophoresis on 8–12% gels. 
For immunoblotting, proteins were transferred to polyvi-
nylidene fluoride membranes (Immobilon-P, Millipore, 
Bedford, MA, USA). After blocking with 5% milk powder 
in Tris-buffered saline/0.1% Tween-20 for 30 min, blots 
were incubated with the primary antibodies: rabbit anti-
ATP6V0a4 serum (1:1000) [72], rabbit anti-ATP6V0a2 
(a kind gift of Dr. X. S. Xie, Dallas, TX, USA) [51, 64], 
rabbit anti-ATP6V1B2 serum (1:5000 raised against the 
sequence EFYPRDSAKH, Pineda Berlin, Germany), 
mouse monoclonal anti-ATP6V1E2 (1:1000, a kind gift 
of Dr. S. L Gluck, University of California, San Fran-
cisco, CA,USA) [4], rabbit polyclonal anti-NaPi-IIa 
(1:5000) [16], sheep anti-Megalin (1:10.000, a kind gift 
from Dr. Erik Ilsø Christensen, Aarhus University, Den-
mark) [42], rabbit anti-cubilin (1:1000, a kind gift from 
Dr. Erik Ilsø Christensen, Aarhus University, Denmark), 
rabbit anti-VDBP (1:2500, Dako, A0021), rabbit-human 
transferrin (1:2000, Dako, A0061), rabbit anti-NHE3 
(1:1000, StressMarq,SPC-400D), rabbit anti-(P)RR 
(1:500, Sigma, HPA003156), mouse anti-Na+/K+ ATPase 
α (H-3) (1:5000, Santa Cruz, sc-48345), rabbit anti-mTOR 
(1:1000, #2972, Cell Signaling Technology, Boston, MA, 
USA), rabbit anti-phospho-mTOR (1:1000, #2974, Cell 
Signaling Technology, Boston, MA, USA), and mouse 
monoclonal anti-β-actin antibody (1:5000, A5441, Sigma), 
either for 2 h at room temperature or overnight at 4 °C. 
Membranes were then incubated for 1 h at room tempera-
ture with secondary anti-rabbit or anti-mouse antibodies 
linked to alkaline phosphatase (1:10,000, S373B, S372B, 
Promega, USA), or anti-sheep antibodies coupled to HRP 
(1:20,000, Dako, P0163), or anti-mouse HRP (1:20,000, 
W402B, Promega, USA). The protein signal was detected 
with the appropriate substrates using the LAS 4000 (Fuji-
film) detection system. All images were analyzed using 
the software Quantity One 4.6.1 (Biorad) to calculate the 
protein of interest/β-actin ratio.
Immunofluorescence staining
Mouse and rat kidneys were perfused in situ through the left 
heart ventricle with a solution containing 10,000 IU Hep-
arin-Na Solution (B. Braun Medical AG, Sempach, Swit-
zerland), 2 mL Lidocain 1% (Streuli Pharma AG, Uznach, 
Switzerland), 2 mL  CaCl2, 16%, 2 mL 0.9% NaCl, and 2 mL 
distilled water. Subsequently, animals were perfused with 3% 
paraformaldehyde in phosphate-buffered saline (PBS). Fixed 
kidneys were cryoprotected with 2.3 M sucrose (Sigma), 
embedded in TissueTec OCT compound 4583 (Sakura Fine-
tek USA, Torrance, CA), and frozen in liquid nitrogen and 
stored at − 80 °C. Kidney cryosections were cut with 5 µm 
thickness on a Leica CM3050S cryostat (Leica Microsys-
tems, Bannockburn, IL). Slides were rehydrated in PBS 
and treated either with 10 mM Tris (Trizma Base, Sigma), 
pH 10 at 100° for 20 min in a pressure cooker (HistoPro, 
Millestone) or 10 mM citric acid (Sigma), pH 6.0 at 98 °C 
for 20 min or 1% sodium dodecyl sulfate (SDS) in PBS. 
In the case of Lamp1 staining, slides were quenched with 
50 mM of  NH4Cl in PBS, three times for 10 min. Unspecific 
sites were blocked with a solution containing 1X PBS/5% 
donkey serum (Sigma)/0.3% Triton X-100 (Sigma) for 
20 min at room temperature. Primary antibodies were diluted 
in 1X PBS/1% BSA/0.3% TritonX-100: goat polyclonal 
anti-(P)RR/ATP6AP2 (1:100, Novus Biologicals, NB100-
1318, used with SDS pretreatment); rabbit polyclonal anti-
ATP6IP2 antibody (1:200, ABCAM ab40790, used with 
microwaving in citric acid), goat polyclonal anti-(P)RR 
antibody (1:100, R&D Systems, #AF5716, used with SDS 
pretreatment), rabbit anti- ATP6V0a4 serum (1:2000) [72], 
goat anti-megalin (1:600, Santa Cruz, sc-16478), rabbit anti-
human transferrin (1:600, Dako, A006), rabbit anti-cubilin 
(1:700, kindly provided by Dr. Erik Ilsø Christensen, Aarhus 
University, Denmark), rat anti-Lamp1 (1:1000, 1D4B was 
deposited to the DSHB by August, J.T. (DSHB Hybridoma 
Product 1D4B)), anti-rabbit LC3B (1:250, Cell Signaling 
Technology, # 2775), goat anti-AQP2 (1:400, Santa Cruz), 
or rabbit anti-AQP2 (1:1000, kindly provided by Dr. J. Loff-
ing, University of Zurich) and kidney sections were incu-
bated with the primary antibodies overnight at 4 °C. Sec-
tions were washed twice with hypertonic PBS (18 g/l NaCl/
PBS) and once with 1X PBS. Afterwards, sections were 
incubated with corresponding secondary antibodies (1:1000) 
(anti-goat Alexa594 and anti-goat Alexa488, anti-rat Alexa 
647, anti-rabbit Alexa 488, and anti-rabbit Alexa594 (Invit-
rogen, Switzerland), phalloidin-Texas Red® (1:100, Molecu-
lar Probes), phalloidin-A647 (1:1000, Abcam, ab176759), 
and DAPI (1:1000, Sigma-Aldrich, Buchs, Switzerland) for 
1 h at room temperature. Slides were washed twice with 
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hypertonic PBS and then once with 1X PBS before being 
mounted with Dako glycergel mounting medium. Semi-
thin Sects. (200 nm thickness) were cut with an ultrami-
crotome (Leica Microsystems Leica EM FCS) and stained 
with Toluidine Blue O (T3260 Sigma-Aldrich). Semi-thin 
sections were visualized with slide-scanner Axio Scan.Z1 
Zeiss, Objective Plan Apochromat 40x, NA 0.95 air (Zeiss 
Germany). Immunofluorescence sections were either visual-
ized with a confocal laser scanning microscope (Zeiss LSM 
700, Carl Zeiss) or a Leica DFC490 charged coupled device 
camera attached to a Leica DM 6000 fluorescence micro-
scope (Leica, Wetzlar, Germany). The confocal microscope 
pinhole was set at 1 Airy unit and pixel size at 90 nm and 
a 40 × /1.3 oil DIC M27 objective was used. Images were 
processed (overlays) using Adobe Photoshop and ImageJ 
software (http:// rsb. info. nih. gov/ ij/).
Endocytic marker injection and tissue fluorescence 
measurement
Dextran-FITC 10 kDa (D1821, Molecular Probes) was used 
as fluid-phase endocytosis marker and human recombinant 
transferrin (T3795, Sigma) was used as receptor-mediator 
endocytosis marker [47]. Dextran-FITC and human trans-
ferrin were diluted in the same isotonic saline solution 
(6.25 mg/mL for dextran-FITC and 50 mg/mL for trans-
ferrin) and injected into the tail vein. Cytoplasmic frac-
tions for kidney protein extraction were used for measuring 
FITC in the tissue with Nanodrop 3300 Fluorospectrometer 
(ThermoScientific). Samples were normalized for protein 
content and blanked with a sample from an animal that was 
not injected.
Statistical analysis
Statistical significances were calculated by Student’s t-test. 
P < 0.05 was considered significant. Results are presented 
as mean ± SEM.
Results
Knock‑down of Atp6ap2 in rats
Transgenic rats (Sh rats) expressing an shRNA against 
Atp6ap2 were generated by inserting a transgene under the 
control of tetracycline repressor protein (TetR) allowing the 
controlled activation of the shRNA by doxycycline treatment 
(Fig. 1A). Integration of the transgene and expression of the 
TetR mRNA and protein was confirmed by PCR (Fig. 1B) 
and immunoblotting (Fig. 1C). We could detect TetR pro-
tein in all organs tested. Expression of the Atp6ap2 protein 
and mRNA were studied in more detail in the kidney from 
animals 10 days after doxycycline treatment. RT-qPCR for 
Atp6ap2 mRNA in the whole kidney showed a decrease by 
approx. 90% of the transcript in Sh rats when compared 
with control rats (Wt) (Fig. 1D). Similarly, immunohisto-
chemistry on kidney sections stained for the ATP6ap2 and 
the  H+-ATPase subunit a4 (Fig. 1E) demonstrated greatly 
reduced or absent ATP6ap2-related staining in proximal 
tubule and intercalated cells.  H+-ATPase subunit a4 staining 
was used as a positive control, since both proteins share the 
same localization in the kidney [17]. Thus, Atp6ap2 shRNA 
rats present with an efficient knock-down of Atp6ap2 mRNA 
and protein in the kidney.
At the level of light microscopy, similar overall renal 
morphology was seen in Wt and Sh rats (Fig. 1F). However, 
in Sh rat kidneys, we could observe some areas containing 
vacuoles, suggesting degeneration of some nephrons. Such 
areas were less seen in Wt kidneys. The gross morphology 
of glomeruli was undistinguishable between Wt and Sh 
rats unlike in mice with podocyte-specific deletion of the 
ATP6ap2 [49, 59].
Body weight, food and water intake, was not different in 
Wt and Sh rats 10 days after doxycycline treatment. Urine 
and blood analysis revealed normal electrolytes and pH. 
BUN and blood phosphate levels were elevated in Sh rats 
whereas creatinine clearance decreased consistent with a 
mild impairment of renal function. In urine, sodium levels 
were lower while phosphate and creatinine excretion was 
increased in Sh rats (Table 1).
ATP6ap2 knock‑down impairs proximal tubule 
receptor‑mediated endocytosis
Sh rats exhibited mild albuminuria and low molecular 
weight proteinuria as indicated by elevated vitamin D 
binding protein (VDBP) in urine (Fig. 2A,B). To further 
determine which endocytic pathway may be impaired, we 
coinjected in both animal groups a marker for fluid endo-
cytosis (dextran-FITC, 10 kDa) and a marker for receptor-
mediated endocytosis (human transferrin) and fixed kidneys 
for immunohistochemistry 10 and 40 min after injection. 
Dextran-FITC was co-stained with phalloidin (marker for 
the brush border membrane) to allow subcellular determina-
tion of dextran localization. By fluorescence microscopy, no 
differences were observed in FITC intensity or subcellular 
localization between animal groups at 10 min. In addition, 
the relative amount of FITC in kidney tissue at 10 min was 
similar between animal groups (Fig. 2C,D). Dextran-FITC at 
40 min was also analyzed (Supplementary Fig.1) and stain-
ing intensity was weaker than at 10 min but showed similar 
subcellular localization in both genotypes. Thus, fluid-phase 
endocytosis was not affected by (P)RR/AT6ap2 knock-down.
In contrast, endocytosis of human transferrin was altered 
in Sh rats compared to Wt animals. We used antibodies 
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recognizing human but not endogenous rat or mouse trans-
ferrin and detected a weaker transferrin-related staining in 
kidneys from Sh rats 10 min after injection whereas 40 min 
after injection more pronounced staining was found in Sh rat 
kidneys than in Wt kidneys (Fig. 2E). At 10 min, transfer-
rin was localized in the subapical region and presented as 
a punctuated pattern as expected [13]. Immunoblotting for 
human transferrin in urine samples collected 10 min after 
transferrin injection showed abundant transferrin in urine 
from Sh rats but very low levels in Wt urine suggesting 
reduced uptake (Fig. 2F). Forty minutes after injection, in 
Wt rats, transferrin staining was almost absent while in the 
Sh rats, transferrin staining accumulated in the perinuclear 
region (Fig. 2E).
The localization of the two major endocytic receptors 
megalin and cubilin was similar in both genotypes at light 
microscopy level (Fig. 2E and supplementary Fig. 2). The 
relative amount of megalin protein was unchanged whereas 
cubilin was more abundant in kidneys from Sh rats (Fig. 3).
ATP6ap2 was suggested to be an accessory subunit of 
 H+-ATPases [31, 36, 67] therefore a loss of ATP6ap2 could 
affect  H+-ATPase regulation and/or function in the endocytic 
pathway. Immunoblotting showed reduced a4  H+-ATPase 
(ATP6V0a4) subunit whereas B2 (ATP6V1B2) and A 
(ATP6V1A) subunits were unaltered (Fig. 3).
The abundance of NaPi-IIa, the main phosphate trans-
porter in the proximal tubule, and NHE3 (sodium-proton 
exchanger 3) is directly or indirectly affected by alterations 
in the endocytic apparatus of the proximal tubule [2, 3, 18] 
NaPi-IIa showed no differences in abundance and NHE3 a 
slight increase in expression, however, not reaching signifi-
cance due to high interindividual variability (Fig. 3).
Kidney‑epithelial cell‑specific ATP6ap2 KO mice
Since Atp6ap2 shRNA rats present with a full-body knock-
down of the ATP6p2 that may impact on overall renal func-
tion and that complicates interpretation of data, we decided 
to examine proximal tubular endocytosis in a kidney-epithe-
lial cell-specific inducible ATP6ap2 knockout (KO) mouse 
model using the well-described doxycycline-inducible 
Pax8-Cre system after crossing with floxed ATP6ap2 mice. 
First, we used a milder induction protocol for Cre activ-
ity [44] as usual based on previous experience suggesting 
that higher doses of doxycycline can also produce effects 
in wildtype mice and with the intention to downregulate 
ATP6ap2 mostly in proximal tubules without producing the 
strong phenotype caused by deletion of ATP6ap2 in the col-
lecting duct [56, 57, 70]. However, to rule out that the milder 
doxycycline protocol (1 mg/mL induction), was too weak to 
reveal a proximal tubule role of ATP6ap2, we used in a sec-
ond and independent series of animals also the conventional 
doxycycline protocol with 2 mg/mL induction. As detailed 
below, the findings in both series are qualitatively very simi-
lar and we report data from the first series in the main body 
of this manuscript. The data from the second series are pre-
sented in the supplementary files. To verify kidney-specific 
ATP6ap2 deletion, we performed RT-qPCR for Atp6ap2 
in the kidney, lung, and heart (Fig. 4A and supplementary 
Fig. 3). Atp6ap2 was downregulated in both protocols only 
in kidneys from Flox/Pax8 + mice but not in other organs 
or kidneys from control Wt/Pax8 + mice. Western blotting 
using total kidney protein homogenate confirmed reduction 
of ATP6ap2 protein expression by about 50–75% (Fig. 4B, 
suppl. Figure 3). Residual mRNA and protein expression 
may be due to expression in renal cells negative for Pax8 
(i.e., podocytes) or incomplete deletion in epithelial cells. 
Immunohistochemistry using three different antibodies 
against ATP6ap2 demonstrated almost complete deletion of 
ATP6ap2 from proximal tubules but widely preserved stain-
ing in intercalated cells of the connecting tubule and medul-
lary collecting ducts (Fig. 4C and supplementary Figs. 6 and 
7). We noted major differences in specificity of commercial 
Table 1  Metabolic and urine parameters from Wt and Sh rats. Water 
and food intake and urine volume were monitored in metabolic cages 
under baseline conditions. After adaptation, 24  h urine and blood 
were collected for analysis. Statistical analysis was performed using 
Student’s t-test (n = 6/genotype) *p < 0.05, **p < 0.01, ***p < 0.001
Parameters Wt Sh
Body weight (g) 303.8 ± 10.7 268.1 ± 18.7
H2O intake (g/g BW) 0.13 ± 0.01 0.13 ± 0.01
Food intake (g/g BW) 0.09 ± 0.01 0.09 ± 0.01
Plasma
pH 7.47 ± 0.01 7.51 ± 0.02
Glucose (mg/dL) 225.8 ± 22.2 206.8 ± 16.6
Na+ (mM) 136.5 ± 1.0 136.2 ± 0.3
K+ (mM) 4.37 ± 0.15 3.62 ± 0.22
Ionized  Ca2+ (mM) 0.84 ± 0.14 0.80 ± 0.05
Cl− (mM) 97.8 ± 0.8 95.7 ± 0.6
Phosphate (mg/dL) 8.6 ± 0.4 9.8 ± 0.3 *
Prealbumin (mg/dL) 1.72 ± 0.31 1.53 ± 0.22
Creatinine (mg/dL) 0.30 ± 0.02 0.40 ± 0.01
BUN (mg/dL) 35.2 ± 1.0 48.3 ± 2.6 ***
Urine
Urine (g/g BW) 0.04 ± 0.01 0.03 ± 0.01
Creatinine (mg/dL) 72.2 ± 10.3 111.9 ± 13.2 *
Creatinine Clearance (mL/min) 1.9 ± 0.2 1.5 ± 0.2
Na+ (mM)/Crea (mg/dL) 95.0 ± 8.3 71.2 ± 22.8 **
K+ (mM)/Crea (mg/dL) 2.60 ± 0.11 2.73 ± 0.14
Ca2+ (mM)/Crea (mg/dL) 0.020 ± 0.003 Not detectable
Mg2+ (mg/dL)/Crea (mg/dL) 0.57 ± 0.10 0.32 ± 0.15
Phosphate (mg/dL)/Crea (mg/dL) 0.08 ± 0.08 1.71 ± 0.20 ***
Cl− (mM)/Crea (mg/dL) 2.2 ± 0.1 2.1 ± 0.1
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antibodies against ATP6ap2 as shown in Fig. 4 and suppl. 
Figures 7 and 8.
Flox/Pax8 + mice with the first, lower doxycycline pro-
tocol had normal blood acid–base and electrolyte status 
and no evidence for reduced kidney function unlike rats. 
Urine analysis showed higher diuresis and mild sodium 
and potassium losses with reduced urinary calcium excre-
tion consistent with the deletion of the ATP6ap2 mostly 
from proximal tubules (Table  2). Mice receiving the 
higher doxycycline dose had mildly elevated plasma cre-
atinine levels but otherwise normal plasma values includ-
ing BUN. Urine data showed similar urine pH but reduced 
creatinine clearance in Flox/Pax8 + mice (supplementary 
table 1). Thus, Flox/Pax8 + with the higher doxycycline 
protocol showed some signs of renal impairment.
Fig. 2  Preserved fluid-phase 
endocytosis but impaired 
receptor-mediated endocytosis 
in (P)RR/ATP6ap2 deficient 
rats. A Albuminuria in Sh rats 
detected by Coomassie blue 
staining of SDS-Page gels 
loaded with urine samples nor-
malized to creatinine (7 mg/mL) 
BSA (7 mg/mL) was loaded 
as positive control. Bar graph 
summarizing data (n = 4 in each 
animal group). Student’s t-test 
*p < 0.05. B Elevated vitamin 
D binding protein (VDBP) in 
urine of Sh rats detected by 
immunoblotting of urine sam-
ples normalized to creatinine 
(7 mg/mL). Bar graph summa-
rizing data from n = 4/genotype. 
C Immunohistochemistry for 
dextran-FITC (10 kDa, green), 
DAPI (blue), and actin/phalloi-
din (red) in kidney slices from 
Wt and shRNA rat 10 min after 
injection (scale bar size 50 µm). 
D Quantification of dextran-
FITC in the cytoplasmic 
fraction of the control and Sh 
rats kidney homogenate. FITC-
dextran was normalized to total 
protein content. E Immunohis-
tochemistry for human transfer-
rin (red), megalin (green), and 
DAPI (blue) in Wt and Sh rats 
kidney 10 min and 40 min after 
injection showed strong residual 
staining of transferrin after 
40 min in Sh rat kidneys (see 
insert) (scale bar size 50 µm). 
F Western blotting for human 
transferrin in Wt and Sh rat 
urine 10 min after injection. 
Urine samples were normal-
ized to creatinine (7 mg/mL). 
Bar graph summarizing data 
from n = 4/genotype. Statistical 
analyses were performed using 
Student’s t-test **p < 0.01
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ATP6ap2 deletion in proximal tubule causes a defect 
in receptor‑mediated endocytosis
Like the rat model, Flox/Pax8Cre + mice had albuminuria 
and low molecular weight proteinuria loosing VDBP and 
procathepsin B with urine (Fig. 5 and supplementary Fig. 4). 
In the low doxycycline group, coinjection of the endocytic 
markers dextran-FITC (10 kDa) and human transferrin con-
firmed that deletion of the ATP6ap2 affects the receptor-
mediated endocytosis pathway (Fig. 6). Dextran-FITC local-
ization and intensity of staining was similar between animal 
groups at two time points (10 and 40 min after injection). 
Human transferrin staining was similar between genotypes 
10 min after injection but showed, like in Sh rats, delayed 
clearance of transferrin in Flox/Pax8 + mice 40 min after 
injection with perinuclear accumulation (Fig. 6B). Costain-
ing of human transferrin with Lamp1, a lysosomal marker, 
in kidneys 40 min after injection (Fig. 6C), revealed that 
in ATP6ap2-deficient animals human transferrin did not 
overlap with Lamp-1 stained lysosomes suggesting delayed 
transferrin processing (Fig. 6C). The same reduced colocali-
zation of recombinant human transferrin and Lamp-1 was 
seen 40 min after injection in mice receiving the higher dose 
of doxycycline (supplementary Fig. 5).
Western blotting demonstrated reduced expression of the 
a4 (ATP6V0a4) and EII (ATP6V1EII)  H+-ATPase subunits 
Fig. 3  Altered expression of 
proteins involved in receptor-
mediated endocytosis. A Brush 
border membrane preparations 
of control and Sh rat kidneys 
were used for blotting for 
 H+ATPase a4 (ATP6V0a4), 
B2 (ATP6V1B2), and A 
(ATP6V1A) subunits as well 
as for NaPiIIa, NHE3, megalin, 
and cubilin. B Densitometries 
were adjusted to β-actin (load-
ing control). Statistical analysis 
using Student’s t-test (n = 6/
genotype or n = 4/genotype for 
NaPiIIa). *p < 0.05 ***p ≤ 0.001
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whereas the a2 (ATP6V0a2) and A (ATP6V1A) subunits 
showed a strong trend to be lowered. ATP6V1B2 protein 
abundance was unaltered. Megalin, cubilin, and NHE3 abun-
dance was not altered (Fig. 7). Similar results were obtained 
for the a4 and EII  H+-ATPase subunits and megalin in the 
second group of animals (supplementary Fig. 6).
mTOR signaling is linked to lysosomal function [5, 34, 
74]. Vice versa, inhibition of mTOR by rapamycin in mice 
caused megalin downregulation and proteinuria through a 
 H+-ATPase-dependent mechanism [21]. However, in Flox/
Pax8 + kidneys, phosphorylated mTOR and total mTOR 
amount were unaltered (Fig. 8).
mTOR signaling and ATP6ap2 are linked to autophagy 
[29, 43, 59]. Immunoblotting and staining for the micro-
tubule-associated protein 1A/1B-light chain 3 or LC3-B, 
a subunit of the autophagosome showed accumulation of 
LC3-B in proximal tubules from ATP6ap2 deficient mice 
but not in wild type controls (Fig. 8B, C).
Discussion
In this study, we demonstrated that ATP6ap2 plays a role 
in receptor-mediated endocytosis and lysosomal function 
in the proximal tubule. Both ATP6ap2-Sh rats and Flox/
Fig. 4  Generation of kidney-
epithelial cell-specific ATP6ap2 
ablation in mouse. A RT-qPCR 
analysis of total mRNA of kid-
neys, lungs, and hearts from Wt 
and Flox/Pax8 + mice treated 
with 1 mg/mL doxycycline 
(low dose). Atp6ap2 mRNA 
abundance was normalized to 
HPRT. Statistical analysis was 
performed using Student’s t-test 
(Wt/Pax8 + : n = 4 and Flox/
Pax8 + : n = 5) ***p < 0.001. B 
Western blotting for ATP6ap2 
in total membrane preparations 
from the kidney of Wt and Flox/
Pax8 + mice and summary of 
data as bar graph. Statistical 
analysis was performed using 
Student’s t-test (Wt/Pax8 + : 
n = 4 and Flox/Pax8 + : n = 5) 
*p < 0.05. C Immunohisto-
chemistry for ATP6ap2 (red), 
AQP2 (green), and DAPI (blue) 
in kidney sections from Wt/
Pax8 and Flox/Pax8 + mice with 
proximal tubules (upper panels) 
and medullary collecting ducts 
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Pax8Cre + mice showed excretion of albumin and low 
molecular weight proteins in urine, delayed processing of 
substrates of the receptor-mediated endocytosis pathway, 
and reduced expression of other key molecules involved in 
this process as well as accumulation of the LC3-B subu-
nit of the autophagosome. All these changes are consistent 
with impaired lysosome function and reduced activity of the 
receptor-mediated endocytosis pathway.
We used two rodent models to demonstrate a role of 
ATP6ap2 in proximal tubule endocytosis of low molecular 
weight proteins and lysosomal function. Both models yield 
similar results as discussed below in more detail. The mouse 
model used is similar to previously published models with 
a more severe renal defect including an urinary concentra-
tion defect, salt loss, and distal renal tubular acidosis [56, 
57, 70]. However, there are major differences between these 
models and our model. We induced Pax8-driven Cre activity 
in animals 6–8 weeks old whereas in the published models 
doxycycline was given already to mothers or to animals 
after weaning. Moreover, we used in the first model a lower 
doxycycline dose [44] to induce Cre activity and deletion of 
ATP6ap2 as we had previously observed that higher doses 
resulted also in a transient renal phenotype in animals not 
expressing any transgene. The low-dose doxycycline pro-
tocol resulted in an almost complete deletion of ATP6ap2 
in the proximal tubule but with well-preserved expression 
in the collecting duct thereby circumventing a more severe 
renal damage and phenotype allowing to focus on proximal 
tubule functions. Likewise, the higher dose of doxycycline 
deleted ATPap2 from the proximal tubule but maintained 
most of the intercalated cell expression as evident from 
immunohistochemistry and normal urine pH. Consequently, 
our model did not develop signs of renal acidosis. This is 
important to consider as metabolic acidosis has recently 
been shown to impair proximal tubule endocytosis [11] and 
the defect described here is likely not caused by systemic 
alterations in acid–base balance.
ATP6ap2 associates with  H+-ATPases [15, 36, 41, 
52, 61]. We and others had shown that the ATP6ap2 is 
expressed in the renal proximal tubule and colocalizes 
with  H+-ATPases in this nephron segments [17, 28, 60]. 
 H+-ATPases contribute to several functions of the proximal 
tubule such as reabsorption of bicarbonate, trafficking and 
recycling of membrane proteins, or endocytosis of proteins 
from urine, acidification of vesicles along the endocytic 
pathway, and lysosomes processing or degrading absorbed 
substrates [71].
Several lines of evidence suggest that the ATP6ap2 
modulates  H+-ATPase function in the proximal tubule and 
thereby contributes to receptor-mediated endocytosis and 
lysosomal function. However, our data do not support a role 
of the ATP6ap2 in fluid-phase mediated endocytosis as sug-
gested by data from Drosophila [25] or other generalized 
functions of the proximal tubule. Urine analysis and immu-
noblotting showed no generalized Fanconi-syndrome like 
loss of function as indicated by the absence of glucosuria, 
massive proteinuria, or changes in urine and blood pH. Both, 
Sh rats with reduced ATP6ap2 and ATP6ap2 KO mice, 
showed albuminuria in combination with the presence of 
low molecular weight proteins such as the vitamin D binding 
protein (VDBP) or procathepsin B. Also, injected recombi-
nant transferrin was found in urine of Sh rats. Thus, these 
findings are indicative of reduced proximal tubular protein 
absorption. In the case of the Sh rats, we cannot exclude 
also increased filtration of albumin or transferrin as in these 
animals ATP6ap2 expression in podocytes may be reduced 
and podocyte-specific deletion of ATP6ap2 causes massive 
proteinuria and glomerular damage [49, 59]. Therefore, we 
created a mouse model with deletion of the ATP6ap2 in 
Table 2  Metabolic and urine parameters of Wt and Flox/Pax8 + mice. 
Animals were induced with the low-dose doxycycline protocol (1 mg/
mL). Water and food intake were monitored in metabolic cages under 
baseline conditions. 24 h urine and blood were collected for analysis. 
Statistical analysis was performed using Student’s t-test (n = 8 in both 
groups) *p < 0.05, **p < 0.01, ***p < 0.001
Parameters Wt/Pax8 + Flox/Pax8 + 
Body weight (g) 25.2 ± 1.0 23.6 ± 1.8 *
H2O intake (g/g BW) 0.19 ± 0.02 0.26 ± 0.01 *
Food intake (g/g BW) 0.16 ± 0.02 0.19 ± 0.01
Plasma
pH 7.26 ± 0.03 7.27 ± 0.05
Glucose (mg/dL) 250.5 ± 8.9 238.9 ± 15.3
Na+ (mM) 144.7 ± 1.1 146.0 ± 1.1
K+ (mM) 3.9 ± 0.4 3.2 ± 0.1 *
Ionized  Ca2+ (mM) 0.96 ± 0.23 1.11 ± 0.05
Cl− (mM) 108.2 ± 1.5 109.2 ± 0.1
Phosphate (mg/dL) 5.9 ± 0.1 6.2 ± 0.3
Prealbumin (mg/dL) 1.76 ± 0.42 1.88 ± 0.15
Creatinine (mg/dL) 0.05 ± 0.01 0.07 ± 0.01
BUN (mg/dL) 40.6 ± 5.9 40.7 ± 3.3
Urine
Urine (g/g BW) 0.051 ± 0.009 0.083 ± 0.008 *
Creatinine (mg/dL) 63.0 ± 4.2 42.8 ± 2.9 **
Creatinine clearance (μL/min) 109 ± 35 98 ± 23
Na+ (mM)/Crea (mg/dL) 1.7 ± 0.2 5.8 ± 1.1 **
K+ (mM)/Crea (mg/dL) 6.0 ± 0.3 7.1 ± 0.3*
Ca2+ (mM)/Crea (mg/dL) 0.03 ± 0.01 0.01 ± 0.21*
Mg2+ (mg/dL)/Crea (mg/dL) 1.65 ± 0.10 1.70 ± 6.25
Phosphate (mg/dL)/Crea (mg/dL) 6.7 ± 0.4 7.1 ± 0.6
Cl− (mM)/Crea (mg/dL) 4.0 ± 0.2 5.0 ± 0.3
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the epithelial cells along the nephron with intact expres-
sion of the protein in podocytes and found similar urinary 
excretion of albumin, VDBP, and procathepsin. Absorption 
of these proteins depends on the initial recognition by and 
binding to the multi-specific receptors megalin and cubilin 
present in the brush border membrane [47]. Deletion of the 
ATP6ap2 did not alter overall abundance of these receptors 
and also did not affect their localization at the level of light 
microscopy. Proteins bound to these receptors are then inter-
nalized in a receptor-ligand complex and further processed 
through early endosomes to late endosomes and lysosomes. 
In our experiments, four different ligands of these recep-
tors were further investigated: albumin and VDBP which 
are internalized by both megalin and cubilin, procathepsin B 
which is preferentially absorbed by megalin, and transferrin 
a preferred substrate for cubilin [47]. All four proteins were 
found at elevated levels in urine suggesting a defect common 
to both receptors. The number of urine samples available for 
analysis was low precluding a more detailed analysis and 
more robust statistics. Nevertheless, more detailed analysis 
of transferrin internalization showed that transferrin is taken 
up from urine, albeit at somewhat lower rates (as indicated 
by higher urinary excretion after injection of transferrin) 
and that processing of transferrin to lysosomes is delayed as 
suggested by accumulation of transferrin 40 min after injec-
tion and much reduced colocalization of injected transferrin 
with a lysosomal marker (Lamp-1) at this later time point.
The delayed processing of endocytic substrates is most 
likely due to a reduced capacity of endocytic and lysosomal 
vesicles to acidify. A role of the ATP6ap2 in endosomal 
acidification has been described in Xenopus frog embryos 
and linked to reduced  H+-ATPase activity [15]. Consist-
ently, we found decreased expression of several  H+-ATPase 
subunits including the a4 subunit (ATP6V0a4) in Sh rats 
and KO mice as well as the EII (ATP6V1EII) subunit in the 
KO mice. Similarly, ablation of the ATP6ap2 in embryonic 
cardiomyocytes reduced expression of several subunits of 
the  V0 domain of the  H+-ATPase and impaired lysosomal 
acidification [30]. In mice, deletion of ATP6V0a4 causes 
proximal tubular dysfunction and reduced receptor-mediated 
endocytosis with impaired lysosomal function consistent 
with an important role of  H+-ATPases in these processes 
[22]. Whether the lower expression of the a4 subunit in the 
ATP6ap2 deficient rodent models is the consequence of 
absent ATP6ap2 function and/or directly causes the endo-
cytic and lysosomal defect remains unclear at this point.
Fig. 5  Albuminuria and low 
molecular weight proteinuria 
in the absence of the ATP6ap2. 
Urine samples were normal-
ized to creatinine. Bovine 
serum albumin (BSA, 7 mg/
mL) was loaded as posi-
tive control. A Albumin was 
detected by Coomassie blue 
staining whereas B vitamin D 
binding protein (VDBP) or C 
(Pro)cathepsin B was revealed 
by immunoblotting. Data were 
summarized as bar graphs 
(n = 4/genotype. Student’s t-test 
*p < 0.05, ***p < 0.001
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Defects in lysosomal acidification due to reduced or 
absent  H+-ATPase function can cause altered mTOR sign-
aling and activation of the autophagosome as in X-linked 
autophagic myopathy due to mutations in the VMA21 
protein required for lysosomal  H+-ATPase assembly [55] 
or in podocytes with specific deletion of the ATP6ap2 and 
impaired lysosomal function [49, 59]. Also in liver cells 
or pancreatic beta cells, absence or mutation of ATP6ap2 
causes a lysosomal defect with impaired autophagy and 
vacuolation [7, 12, 62]. Fusion of lysosomes and autophago-
somes occurs independently from lysosomal acidification 
but requires  H+-ATPases [38]. Lysosomes act as signal-
ing platforms associating with the mTOR complex 1 and 
 H+-ATPase function is required for mTORC1 signaling 
whereas in turn mTOR signaling regulates  H+-ATPase 
expression [50, 75]. mTOR is also a regulator of autophago-
some function and autophagosome-lysosomal fusion and 
reduced mTOR signaling impairs autophagosome-lysosome 
fusion [27, 39]. Thus, deletion of the ATP6ap2 may impair 
 H+-ATPase assembly and function, thereby decreasing endo-
somal and lysosomal acidification as well as mTOR signal-
ing. Consequently, lysosome-autophagosome fusion may be 
decreased due to  H+-ATPase-dependent but acidification-
independent as well as mTOR-dependent mechanisms. Of 
note, increased levels of the ATP6ap2 in a podocyte cell 
line enhance mTOR signaling and reduce autophagosome 
expression and activity [35]. We found in the ATPap2 
KO mouse models increased accumulation of the LC3B 
autophagosome subunit in proximal tubule cells whereas 
mTOR signaling appeared not to be affected.
In the rat model, Sh rats showed altered tubular mor-
phology in H&E stained sections with vacuoles promi-
nently present in proximal tubules. While the cause of 
these vacuoles remains elusive, the vacuoles potentially 
Fig. 6  Delayed receptor-medi-
ated endocytosis in ATP6ap2 
deleted mice. WT/Pax8 + and 
Flox/Pax8 + mice were 
coinjected with dextran-FITC 
(10 kDa) and human recombi-
nant transferrin. Kidneys were 
collected 10 and 40 min after 
injection. A Immunohistochem-
istry for dextran-FITC,10 kDa 
(green), DAPI (blue), and actin/
phalloidin (red) in kidney slices 
from Wt and Flox/Pax8 + mice 
10 and 40 min after injection. 
B Immunohistochemistry for 
human transferrin (red), DAPI 
(blue), and megalin (green) 
in kidneys from Wt and Flox/
Pax8 + mice 10 and 40 min after 
injection. C Immunohistochem-
istry for Lamp-1 (green) and 
human transferrin (red) 40 min 
after injection. Scale bar size 
50 µm for all pictures
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impair overall proximal tubule function and may par-
ticularly impact on endocytosis and vesicular trafficking 
contributing to the observed defect in endocytosis. How-
ever, the fact that a similar defect in endocytosis was also 
observed in the mouse models with apparently normal 
proximal tubular morphology (at least by light micros-
copy) strongly suggests that the loss of ATP6ap2 through 
mechanisms discussed above impairs endocytosis and pro-
cessing of cargo.
In summary, genetic deletion of the (P)RR/ATP6ap2 from 
the proximal tubule in rats and mice causes albuminuria 
and low molecular weight proteinuria paralleled by reduced 
expression of several  H+-ATPase subunits and delayed pro-
cessing of substrates of receptor-mediated endocytosis to 
lysosomes. Lysosomal dysfunction is suggested by accumu-
lation of the LC3-B subunit of the autophagosome. Thus, 
the ATPap2 facilitates receptor-mediated endocytosis in the 
proximal tubule possibly by modulating  H+-ATPases.
Fig. 7  Deletion of the ATP6ap2 
alters expression of major 
proteins in the endocytic 
pathway. A Brush border 
membrane preparations from 
kidneys of Wt/Pax8 + and Flox/
Pax8 + mice were blotted for the 
 H+ATPase a4 (ATP6V0a4), a2 
(ATP6V0a2), EII (ATP6V1EII), 
B2 (ATP6V1B2), and A 
(ATP6V1A) subunits as well 
as for NHE3, megalin, and 
cubilin. B Densitometries were 
normalized to β-actin (load-
ing control). Student’s t-test 
(n = 4 per group), **p ≤ 0.01, 
***p ≤ 0.001
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